Pharma

Basel, Switzerland - Feburary 07, 2023: The twin tower of the Roche Tower

Roche Accelerates Anti-Obesity Drug Development to Rival Eli Lilly and Novo Nordisk

Strategic move boosts the Swiss pharmaceutical company's shares.

Biovac Advances Africa's Vaccine Production with Sanofi and EuBiologics Partnerships

In a significant move to bolster local vaccine production across Africa, South African pharmaceutical company Biovac has entered into strategic agreements with Sanofi and EuBiologics.

NICE Approves Vertex’s Modulator Drugs for Cystic Fibrosis: A Landmark Decision for the NHS

The National Institute for Health and Care Excellence (NICE) has granted approval for the life-changing cystic fibrosis modulator drugs—Kaftrio, Symkevi, and Orkambi—to be made available through the NHS in England.

Bayer Pharmaceuticals Shakes Up Leadership Structure

Bayer Pharmaceuticals implements leadership streamlining amid restructuring efforts.

FDA Approves the First Prognostic Test for Alzheimer’s Progression

Darmiyan receives FDA approval for BrainSee, the first prognostic test for predicting likelihood of progression to Alzheimer's dementia.

Chipscreen NewWay Biosciences Initiates Phase I Clinical Trial

First advanced solid tumour patient dosed in a phase I clinical trial assessing preliminary efficacy of bispecific antibody, NWY001.